Why would they risk running short on stock - surely it would make more financial sense to mark down the old stock than risk losing out on sales through lack of on shelf availability?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025